HealthTech Finland thanks the Commission for opening the Call for Evidence for the simplification of rules for data, cybersecurity and artificial intelligence (Digital Omnibus) Concerns raised by health technology SMEs require specific attention through targeted solutions.
HF
Healthtech Finland
NGO · Finland
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts (staff, costs, accreditations) are not available for it.
5
positions filed
in the 665 files tracked
4
legislative files
of 665 tracked
5
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Track Healthtech in PolicySpeak: request access →
Work at Healthtech Finland? so we know who speaks for it.
Their record over time
Healthtech Finland filed 5 positions between 3 Oct 2025 and 5 Aug 2026, across 4 of the 665 legislative files tracked here, attaching a full position paper 5 times.
2025 · 3 filed2026 · 2 filed
What they argued
Healthtech Finland thanks the Commission for the possibility to give feedback on the proposal for the amendment of the medical device regulations (MDR and IVDR). The MDR and IVDR change proposal addresses many of the pressing questions and challenges the healthcare sector, healthcare organisations and professionals, as well as the medical device industry, are currently experiencing.
HealthTech Finland thanks the Commission for opening the Call for Evidence for the medical device regulations (MDR and IVDR). The performance and safety of medical devices (MD) and in vitro diagnostics medical devices (IVD) is crucial to European patients. However, also the availability of devices to patients is a critical part of high-quality care and patient safety.
Healthtech Finland welcomes the opportunity to provide feedback on the proposal for the Biotech Act (I). Healthtech Finland supports the Act, and its aims to strengthen the EU health biotechnology ecosystem, support innovation, and enhance European competitiveness.
The European Innovation Act is a timely and necessary initiative to address the fragmentation and inefficiencies that hinder innovation across the EU. However, one critical dimension remains underrepresented in the current framing: regulatory literacy. Regulatory literacy the ability of innovators to understand and navigate regulatory frameworks is foundational to the success of any innovation ecosystem.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Healthtech Finland next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Showing 5 of 124.
Is this your organization?
Everything on this page comes from Healthtech Finland’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.